Nasrin Sharifi
- Epidemiology top 10%
- Molecular Biology
- Physiology top 10%
- Pathology and Forensic Medicine top 10%
- Endocrinology, Diabetes and Metabolism top 10%
- Co-authors
- Reza AmaniEskandar HajianiBahman CheraghianZatollah AsemiMohsen TaghizadehHamed MirzaeiFariba RayganRoxana Sahebnasagh
- Topics
- Liver Disease Diagnosis and Treatment (4 papers)Vitamin D Research Studies (3 papers)Pancreatitis Pathology and Treatment (3 papers)
- Journals
- SHILAP Revista de lepidopterologíaPLoS ONEScientific Reports
In The Last Decade
Nasrin Sharifi
34 papers receiving 889 citations
Peers
Comparison fields: 5 of 103
- Epidemiology 279
- Molecular Biology 230
- Physiology 195
- Pathology and Forensic Medicine 168
- Endocrinology, Diabetes and Metabolism 148
Countries citing papers authored by Nasrin Sharifi
This map shows the geographic impact of Nasrin Sharifi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nasrin Sharifi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nasrin Sharifi more than expected).
Fields of papers citing papers by Nasrin Sharifi
This network shows the impact of papers produced by Nasrin Sharifi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nasrin Sharifi. The network helps show where Nasrin Sharifi may publish in the future.
Co-authorship network of co-authors of Nasrin Sharifi
This figure shows the co-authorship network connecting the top 25 collaborators of Nasrin Sharifi. A scholar is included among the top collaborators of Nasrin Sharifi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nasrin Sharifi. Nasrin Sharifi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 1 | |
| 3 | 5 | |
| 4 | 5 | |
| 5 | 12 | |
| 6 | 4 | |
| 7 | 18 | |
| 8 | 2 | |
| 9 | 3 | |
| 10 | 32 | |
| 11 | Metabolic Response to Mulberry Extract Supplementation in Patients With Diabetic Nephropathy: a Randomized Controlled Trial. | 14 |
| 12 | 17 | |
| 13 | 6 | |
| 14 | 1 | |
| 15 | 15 | |
| 16 | 66 | |
| 17 | 100 | |
| 18 | 45 | |
| 19 | 28 | |
| 20 | 198 |
About Nasrin Sharifi
Nasrin Sharifi is a scholar working on Nephrology, Biochemistry and Nutrition and Dietetics, having authored 34 papers that have together received 900 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (4 papers), Vitamin D Research Studies (3 papers) and Pancreatitis Pathology and Treatment (3 papers). The work is most often cited by research in Hepatology (99 citations), Biochemistry (65 citations) and Nutrition and Dietetics (147 citations). Nasrin Sharifi has collaborated with scholars based in Iran and Canada. Frequent co-authors include Reza Amani, Eskandar Hajiani, Bahman Cheraghian, Zatollah Asemi, Mohsen Taghizadeh, Hamed Mirzaei, Fariba Raygan, Roxana Sahebnasagh, Reza Arefnezhad and Mohammad Hossein Pourhanifeh. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.